Hikma Pharmaceuticals PLC (HIK) To Go Ex-Dividend on March 20th

Hikma Pharmaceuticals PLC (LON:HIK) announced a dividend on Wednesday, February 26th, DividendData.Co.Uk reports. Investors of record on Thursday, March 20th will be given a dividend of $0.48 per share on Thursday, May 1st. This represents a yield of 1.8%. The ex-dividend date of this dividend is Thursday, March 20th. This is a 50.0% increase from Hikma Pharmaceuticals’s previous dividend of $0.32. The official announcement can be accessed at this link.

Hikma Pharmaceuticals Trading Up 1.1 %

LON:HIK traded up GBX 22 ($0.29) during trading hours on Tuesday, hitting GBX 2,052 ($26.65). The company had a trading volume of 76,300,625 shares, compared to its average volume of 3,417,024. The company has a debt-to-equity ratio of 55.82, a current ratio of 1.66 and a quick ratio of 1.27. The company has a market capitalization of £5.69 billion, a PE ratio of 20.14, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41. The stock has a 50-day moving average price of GBX 2,177.22 and a 200 day moving average price of GBX 2,014.40. Hikma Pharmaceuticals has a 52 week low of GBX 1,750 ($22.73) and a 52 week high of GBX 2,360 ($30.65).

Analysts Set New Price Targets

HIK has been the subject of several recent research reports. Berenberg Bank reissued a “buy” rating and set a GBX 2,560 ($33.25) price objective on shares of Hikma Pharmaceuticals in a research report on Monday, March 10th. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Hikma Pharmaceuticals in a research report on Friday, March 7th.

About Hikma Pharmaceuticals

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.